Galena Biopharma, Inc.

NASDAQ: GALE
$0.26
-$0.01 (-5.1%)
Closing Price on December 29, 2017

GALE Chart and Intraday Price

GALE Company Data

Asset Type ETF
Exchange NASDAQ
Sector Healthcare
Industry Drugs

GALE Articles

Biostage, Fossil Group, Galena Biopharma, and Himax posted new 52-week lows on Friday.
Gilead Sciences, Gale Biopharma, Teva, and Fitbit post new 52-week lows Wednesday.
Not that many biotech and pharma companies were on the move Wednesday, but a few of the smaller caps made splash, while one giant company posted a massive loss.
DryShips, Stage Stores, Galena Biopharma, and Diplomat Pharmacy post new 52-week lows on Monday.
Galena Biopharma, Inc. (NASDAQ: GALE) saw its shares jump on Wednesday after a key U.S. Food and Drug Administration (FDA) approval. The company announced that it has confirmed the regulatory pathway...
24/7 Wall St. has collected several big FDA decisions and mid- to late-stage trials that should be coming up in November and December.
Despite Brexit absolutely rocking the market over a week ago, the broad markets made a solid comeback leading most people to believe that this was just one big head fake. Some companies made runs in...
Galena Biopharma, Inc. (NASDAQ: GALE) is absolutely crashing on Wednesday after the company released further information regarding its Breast Cancer clinical trial. The company announced the...
FDA rulings can make or break some companies. 24/7 Wall St. has collected eight key FDA decisions coming up in 2016 or 2017.
Source: ThinkstockAt 24/7 Wall Street we have been running weekly research screens to scan the brokerage firms we cover for the stocks that are cut to Underperform or Sell ratings. The higher the...
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Tuesday February 18, 2014. They include BlackBerry, Care.com, Lululemon Athletica, Tesla Motors...
Here are the top biotech stocks to buy that are trading near the $5 dollar level. We have updated coverage on stocks we have reported on before, and added some top new names to the list.
Source: ThinkstockEvery quarter we like to review the research at the top firms we cover and look for any new stocks to buy that are priced either slightly above or under $5 per share. In the past,...
24/7 Wall St. ran a screen of the Wall Street firms we cover looking for biotech stocks trading under $10 that had big upside potential for 2014. These are potentially the next great growth engines...
Source: ThinkstockWith less than a week left in what has been the best year for the S&P 500 since 1997, we have reviewed our top Wall Street firms for their stocks priced under $10 that may have...